 Infectious Disease Special Edition | FDA Fast Tracks NS5A Inhibitor for HCV Infectious Disease Special Edition Low potential for drug–drug interactions, thus greater prospects for treating HCV patients with comorbidities, coinfected with HIV or pre- or post-liver transplantation. Current treatment options for chronic HCV infection are limited by their ... |
